Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis.

Autor: Xu, Huilin1 (AUTHOR) xhlcdd@163.com, Cao, Dedong2 (AUTHOR), Zhou, Dingjie2 (AUTHOR), Zhao, Nan2 (AUTHOR), Tang, Xixian2 (AUTHOR), Shelat, Vishalkumar G.3 (AUTHOR), Samant, Hrishikesh4 (AUTHOR), Satapathy, Sanjaya K.5 (AUTHOR), Tustumi, Francisco6 (AUTHOR), Aprile, Giuseppe7 (AUTHOR), He, Anbing1 (AUTHOR), Xu, Ximing2 (AUTHOR), Ge, Wei8 (AUTHOR)
Zdroj: BMC Cancer. 10/19/2023, Vol. 23 Issue 1, p1-10. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje